UBS Maintains Buy on Bruker, Raises Price Target to $102
Portfolio Pulse from Benzinga Newsdesk
UBS analyst John Sourbeer has maintained a Buy rating on Bruker (NASDAQ:BRKR) and increased the price target from $94 to $102.

March 01, 2024 | 4:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst John Sourbeer has reaffirmed a Buy rating on Bruker and raised the price target from $94 to $102.
The increase in price target by a reputable analyst like John Sourbeer suggests a positive outlook on Bruker's stock, likely due to strong company fundamentals or market position. This endorsement can boost investor confidence, potentially leading to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100